Literature DB >> 29643656

Comparison of Conventional Smear and Liquid-based Cytology Preparation in Diagnosis of Lung Cancer by Bronchial Wash and Transbronchial Needle Aspiration.

Aasma Nalwa1, Ritika Walia1, Varsha Singh1, Karan Madan2, Sandeep Mathur1, Venkateshwaran Iyer1, Deepali Jain1.   

Abstract

INTRODUCTION: Liquid-based cytology (LBC), initially developed for screening gynecologic specimens, is now being used in nongynecologic aspiration and exfoliative specimens. In this study, the diagnostic yield and utility of thin-prep (TP) was compared with conventional preparations to ascertain its utility in improving the diagnosis of respiratory lesions.
MATERIALS AND METHODS: Bronchial washings (BW) and transbronchial needle aspirates (TBNA) (bronchoscopy/endobronchial ultrasound-guided) from 70 consecutive patients of mediastinal masses and endo/peribronchial growths were included. The diagnostic yields of both conventional smears and thin-prep were compared. Immunocytochemistry (ICC) was performed on direct/cytospin smears of TBNA/BW and TP slides when the tumor could not be subtyped by morphology. Histopathologic correlation was done.
RESULTS: Although well-preserved morphological features and cleaner background in TP allowed accurate diagnosis of malignancies, diagnostic yield was comparable to conventional preparations. Immunocytochemistry was successfully employed on TP smears which helped in accurate subtyping of the tumors. Few shortcomings of TP smears were uneven distribution of cells, thick cell clusters, and inadequate cellularity.
CONCLUSION: Liquid-based TP preparation is an effective diagnostic tool for respiratory tract cytology, however, results are comparable to conventional smears.

Entities:  

Keywords:  Cytology; respiratory tract; thin prep

Year:  2018        PMID: 29643656      PMCID: PMC5885611          DOI: 10.4103/JOC.JOC_248_16

Source DB:  PubMed          Journal:  J Cytol        ISSN: 0970-9371            Impact factor:   1.000


INTRODUCTION

The role of transbronchial needle aspiration (TBNA) and bronchial washings (BW) is well established for the diagnosis of lung lesions. However, conventional smear interpretation is at times limited by the presence of air-drying artefacts, mucous, blood, and cellular overlap.[1] Liquid-based cytology (LBC), initially introduced for cervical screening, has been increasingly used for exfoliative and nongynecologic cytology in the past decade.[2] The main advantages of LBC are clearer background, uniform cell thickness, and removal of air-drying artefacts.[3] In the present study, our main aim was to compare the diagnostic yield of thin-prep (TP) preparation against the matched conventional preparations of BW (cytospin) and TBNA (aspirate smears) to ascertain its utility in improving the diagnosis of lung cancer. Final diagnosis on the paired biopsy was considered the gold standard. Our aim was not to compare the diagnostic yield of BW and TBNA as indications and sites of both techniques are different with different sensitivity and specificity.

MATERIALS AND METHODS

BW and TBNA (bronchoscopy/endobronchial ultrasound-guided) from 70 consecutive patients (57 males and 13 females; 53.3 ± 13.5 years) of mediastinal masses and endo/peribronchial growths were included over a period of 7 months from March 2015 to September 2015. Ethical clearance was obtained from the Institute's ethics committee (IEC/NP-349/2013). Overall, TBNA and BW were done in 29 and 22 cases, respectively. Both BW and TBNA were performed in 19 cases. TBNA was done for the diagnosis of mediastinal masses or lymphadenopathy and peribronchial lesions. A total of 4 direct smears were prepared comprising two air-dried and two alcohol-fixed slides. On average, two direct smears were examined. BW was done in cases of endobronchial lesions or luminal narrowing due to peribronchial obstruction. Two cytospin smears were prepared per case, one was stained with May–Grunwald–Giemsa (MGG) and the other with Papanicolaou (PAP) stain. Although the indications of TBNA and BW are different, the two techniques were clubbed together in the study to examine the diagnostic yield on TP irrespective of the method used for obtaining the material from the respiratory tract for various lesions. TP was prepared in 57 cases. It was prepared for all patients presenting with lesions in lung and hilar and/or mediastinal lymph nodes who underwent TBNA. TP from BW was done only when a clinical diagnosis of malignancy was present. Only those cases were included in the study whose corresponding biopsy was available. Cases where matching biopsies were not available were excluded from the study. One out of three passes of TBNA was taken for TP in a random manner. The sample (BW/TBNA) was transferred to a fixative (CytoLyt, Hologic Inc., MA, USA). The sample was centrifuged at 600 g for 10 min. The supernatant was discarded and vortexed to resuspend the cell pellet and evaluated for appearance. If bloody, additional CytoLyt washes were given and the material was transferred to a vial containing cytopreservative solution (PreservCyt; Cytyc, Co), which fixed the cells, and slides were prepared with the help of ThinPrep 2000 automated slide processor and stained with PAP stain. Direct aspirate smears of TBNA were processed by fixing in 95% alcohol for PAP and air-dried for MGG staining. Cytospin smears of BW, direct smears of TBNA aspirate, and TP were independently evaluated for adequacy, cellularity, and diagnostic yield (benign, suspicious of malignancy, and malignant)[4] and categorized as unsatisfactory, negative, inconclusive, or positive for malignancy. The diagnostic yields of both conventional preparations and TP were compared. World health organization (WHO) Classification of the Tumours of the lung, Pleura, Thymus and Heart, 2015[5] was used for establishing the diagnosis, and the tumors were subtyped as small cell carcinoma and nonsmall cell carcinoma that were further subtyped into adenocarcinoma and squamous cell carcinoma based on their cytomorphological features. Immunocytochemistry (ICC) for Napsin-A (Clone EP205,1:50 dilution, BioSB, USA), Thyroid Transcription Factor-1 (TTF-1; Clone 8G7G3/1, 1:40 dilution, BioSB, USA), p40 (Clone ZR8, 1:100 dilution, BioSB, USA), chromogranin (Clone SP12,1:200 dilution, Spring Biosciences, USA), and synaptophysin (Syn; CloneSP11,1:200 dilution, Spring Biosciences, USA) was performed on TP slides when the tumor could not be subtyped by morphology alone. Briefly, PAP-stained TP slides or direct smears were dipped in xylene for 12 h, followed by removal of the coverslip by immersion in xylene again overnight. Smears were de-stained by immersing in methanol for 15 min and subjected to ICC. Immunocytochemical staining was performed with a monoclonal antibody using a routine streptavidin-biotin horseradish peroxidase detection system with diaminobenzidine as the chromogen. Antigen retrieval was achieved by boiling slides immersed in citrate buffer (10 mmol/l) at pH 6.0 in a microwave oven for 30 min. To diminish endogenous peroxidase activity, slides were treated with 4% hydrogen peroxide in methanol for 30 min.

RESULTS

Only 57 cases were analyzed where paired biopsy (endobronchial/image-guided lung biopsy) of TP was available [Table 1]. Diagnostic yield of direct smears was 68.4% (39/57) and TP was 57.8% (33/57).
Table 1

Correlation of diagnostic accuracy of TP and smear preparation in 57 cases

Correlation of diagnostic accuracy of TP and smear preparation in 57 cases Direct smears (TBNA)/Cytospin (BW): In 6 cases, smear preparation helped in establishing diagnosis, however, TP was unsatisfactory. These include two cases of small cell carcinoma (SCC), two cases of adenocarcinoma, and one case each of nonsmall cell carcinoma (NSCC) and granulomatous inflammation. ICC was done in direct aspirate smears which was positive for chromogranin, synaptophysin (small cell carcinoma), and TTF-1 (adenocarcinoma). Thin-Prep: On TP, four cases of small cell carcinoma [Figure 1a–d], 5 adenocarcinomas and 7 squamous cell carcinomas were noted. Fifteen cases could not be subtyped on morphology alone and were labelled as NSCC. Two cases showed epithelioid cell granulomas on TP. ICC was performed on 12 NSCC cases, of which 4 were immunopositive for Napsin-A, and TTF-1 and were diagnosed as adenocarcinomas [Figure 1e–h]. Similar results were seen on conventional direct or cytospin smears also with or without hemorrhagic background and air-drying artefacts [Figure 2a–c]. P40 was immunopositive in 4 cases of NSCC and were diagnosed as squamous cell carcinomas [Figure 2d–f]. ICC was negative in 4 cases, of which 1 was a metastatic carcinoma of colon on biopsy and showed immunopositivity for CK20 and was negative for CK7 and TTF-1; biopsy diagnosis was not available in 1 case and 2 showed blood clot and tumor necrosis. In 3 cases of NSCC no ICC was performed.
Figure 1

(a) Small cell carcinoma shows small round cells, minimal to no cytoplasm (PAP stain × 400). (b) On high power, cells have powdery chromatin (PAP stain × 600) (c) and are immunopositive for synaptophysin (ICC × 400) and (d) focally immunopositive for TTF-1 (ICC × 600). (e) TP displays cluster of loosely arranged tumour cells of adenocarcinoma with singly lying columnar epithelial cells in background (PAP stain × 200) (f) having ill-defined borders and prominent nucleoli (PAP stain × 400) (g). Tumor cells show nuclear immunopositivity for TTF-1 (ICC × 400) (h) and cytoplasmic positivity for Napsin- A (ICC × 400)

Figure 2

(a) Conventional preparation of bronchial washing shows hemorrhagic background; TBNA revealed only single cluster rendering diagnosis as inconclusive (PAP stain × 200). (b) Tumor clusters easily seen on TP (PAP stain × 100) (c) having ill-defined cell borders, prominent nucleoli (PAP stain × 400); normal respiratory epithelium show ciliated borders (Inset). (d) Cytospin shows single tumor cell cluster of squamous cell carcinoma in hemorrhagic background (PAP stain × 100). (c) Same case on TP shows cells having high nucleocytoplasmic ratio (PAP stain × 400). (d) Strong immunopositivity for p40 (ICC × 400)

(a) Small cell carcinoma shows small round cells, minimal to no cytoplasm (PAP stain × 400). (b) On high power, cells have powdery chromatin (PAP stain × 600) (c) and are immunopositive for synaptophysin (ICC × 400) and (d) focally immunopositive for TTF-1 (ICC × 600). (e) TP displays cluster of loosely arranged tumour cells of adenocarcinoma with singly lying columnar epithelial cells in background (PAP stain × 200) (f) having ill-defined borders and prominent nucleoli (PAP stain × 400) (g). Tumor cells show nuclear immunopositivity for TTF-1 (ICC × 400) (h) and cytoplasmic positivity for Napsin- A (ICC × 400) (a) Conventional preparation of bronchial washing shows hemorrhagic background; TBNA revealed only single cluster rendering diagnosis as inconclusive (PAP stain × 200). (b) Tumor clusters easily seen on TP (PAP stain × 100) (c) having ill-defined cell borders, prominent nucleoli (PAP stain × 400); normal respiratory epithelium show ciliated borders (Inset). (d) Cytospin shows single tumor cell cluster of squamous cell carcinoma in hemorrhagic background (PAP stain × 100). (c) Same case on TP shows cells having high nucleocytoplasmic ratio (PAP stain × 400). (d) Strong immunopositivity for p40 (ICC × 400) Histopathology was considered the gold standard. Two cases of BW were negative whereas biopsy and TBNA (smear and TP) were positive for tumor. However, biopsies were CT-guided and sampled lung mass directly. TBNAs for staging were done from the subcarinal lymph node which were positive for adenocarcinoma. Of 18 falsely negative cases, three cases of squamous cell carcinomas and one case of SCC showed scant necrosis and cellular debris on smear and TP both. Four cases of NSCC and adenocarcinoma showed only few clusters of atypical/reactive cells which were insufficient to establish the final diagnosis and were inconclusive. Remaining 10 cases (8 NSCC and 2 SCC) showed only bronchial epithelial cells. No false positive case was seen.

DISCUSSION

In the past decade, role of endobronchial ultrasound guided transbronchial needle aspirate (EBUS-TBNA) and conventional TBNA has been well established in diagnosing lesions of the lung and mediastinum.[678910] The procedure is minimally invasive and provides accurate cytology and histology samples for evaluation of lung cancer, its subtyping, as well as predictive marker analysis.[1112] Proper sampling along with accurate diagnosis is essential as the treatment is diagnosis dependent. Direct smear and cytospin preparations from aspirations and BW or brushings have been the mainstay for cytological evaluation in respiratory tract lesions. However, with the advent of LBC and its success in improving the diagnostic efficacy of cervical samples, the present study was designed to compare the accuracy of conventional smears (cytospin and aspirate) and TP. In comparison to cytospin and conventional aspirate smears, TP did not add to the final diagnosis. Excessive hemorrhage, necrosis, and air-drying were some of the problems that were encountered while evaluating the direct smears of TBNA. Although there was not much difference in the tumor cell appearance by the two methods, TP eliminated blood and mucus providing a clean and uniform background. TP showed uneven spread of cell population and thick cell clusters in which it was difficult to see nuclear details. However, for ICC, TP smears offered a clean background without hemorrhage and mucus, hence better interpretation of the results. Nuclear stains (p40 and TTF-1) were not affected by alcohol fixation in TP or conventional preparations. ICC in our study was done in only those cases which were difficult to subtype on morphology alone on TP. Studies have been done to compare the utility of TP over other preparations in respiratory tract cytology with superior results with the LBC.[131415161718] We did not find increased diagnostic yield of TP in comparison to conventional smear preparations [Table 1]. The present study observed that it was better to interpret ICC on TP smears due to clean background. Dabbs et al. reported a clean background and consumption of less antibodies with LBC, and additional smears can be prepared if needed.[19] Another study used a panel of antibodies on LBC and found it suitable for different antigens. In addition, monolayer preparation of TP as well as removal of unnecessary background staining caused by blood and proteinaceous debris enabled easy interpretation of the staining.[20] However, in our experience, nuclear stains are easier to interpret on conventional smears also.[2122232425] We have observed diagnostic challenges in TP in the form of thickened cellular clusters, disruption of architectural pattern, and nonuniformly spread cells. Subtle nuclear moulding of SCC with loss of manually-induced nuclear smearing was another difficulty experienced during the study. Loss of background material such as necrosis and mucus also posed diagnostic dilemma in confirmation of the malignant nature of the lesion. Moreover, the cost per case for TP consumables is higher than that required for direct smears, along with the requirement of trained technical staff for running the machine and trained pathologists who are aware of the morphological changes in the appearance of cells on TP smears are needed.[2627] Overall, there is a learning curve for interpretation of LBC. At our centre we routinely perform rapid on-site evaluation in EBUS-TBNA, however, with LBC it cannot be performed. To conclude, use of TP has not increased diagnostic yield in our series of patients, however, it was helpful in performing ancillary studies and establishing the final diagnosis of lung cancer. The application of both methods may be helpful. TP may be added in respiratory tract cytology as a complimentary method, however, not as a substitute of conventional cytology preparations.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  26 in total

1.  Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart.

Authors:  William D Travis; Elisabeth Brambilla; Allen P Burke; Alexander Marx; Andrew G Nicholson
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

2.  The role of ThinPrep cytology in the investigation of lung tumors.

Authors:  P Konofaos; P Tomos; K Malagari; A Karakatsani; D Pavlopoulos; E Lachanas; M Flessas; A Kostakis; P Karakitsos
Journal:  Surg Oncol       Date:  2007-02-01       Impact factor: 3.279

3.  Liquid-based vs. conventional cytology on respiratory material.

Authors:  Ibrahim M Zardawi; Alison Blight; Sharon Ling; Stephen G Braye
Journal:  Acta Cytol       Date:  2009 Jul-Aug       Impact factor: 2.319

4.  Liquid-Based Cytology Preparation Can Improve Cytological Assessment of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration.

Authors:  Ting Qiu; Hui Zhu; Min Cai; Qingbin Han; Jingyu Shi; Ke Wang
Journal:  Acta Cytol       Date:  2015-03-25       Impact factor: 2.319

5.  c-Myb Overexpression in Cytology Smears of Tracheobronchial and Pulmonary Adenoid Cystic Carcinomas.

Authors:  Archana George Vallonthaiel; Deepali Jain; Varsha Singh; Kavneet Kaur; Karan Madan; Vinay Kumar; Venkateswaran K Iyer; Mehar Chand Sharma
Journal:  Acta Cytol       Date:  2016-12-15       Impact factor: 2.319

6.  Cytomorphology of neuroendocrine tumours of the gallbladder.

Authors:  R Yadav; D Jain; S R Mathur; V K Iyer
Journal:  Cytopathology       Date:  2015-02-18       Impact factor: 2.073

7.  Initial experience with endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) from a tuberculosis endemic population.

Authors:  Karan Madan; Anant Mohan; Irfan I Ayub; Deepali Jain; Vijay Hadda; Gopi C Khilnani; Randeep Guleria
Journal:  J Bronchology Interv Pulmonol       Date:  2014-07

8.  Immunocytochemistry on the Thinprep processor.

Authors:  D J Dabbs; C S Abendroth; R T Grenko; X Wang; G E Radcliffe
Journal:  Diagn Cytopathol       Date:  1997-11       Impact factor: 1.582

9.  Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer: a multicenter study of 774 patients.

Authors:  Neal Navani; James M Brown; Matthew Nankivell; Ian Woolhouse; Richard N Harrison; Vandana Jeebun; Mohammed Munavvar; Benjamin J Ng; Doris M Rassl; Mary Falzon; Gabrijela Kocjan; Robert C Rintoul; Andrew G Nicholson; Sam M Janes
Journal:  Am J Respir Crit Care Med       Date:  2012-04-13       Impact factor: 21.405

10.  EBUS-TBNA provides highest RNA yield for multiple biomarker testing from routinely obtained small biopsies in non-small cell lung cancer patients - a comparative study of three different minimal invasive sampling methods.

Authors:  Gerald Schmid-Bindert; Yongsheng Wang; Hongbin Jiang; Hui Sun; Thomas Henzler; Hao Wang; Lothar R Pilz; Shengxiang Ren; Caicun Zhou
Journal:  PLoS One       Date:  2013-10-29       Impact factor: 3.240

View more
  4 in total

Review 1.  Processing and Reporting of Cytology Specimens from Mediastinal Lymph Nodes Collected using Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: A State-of-the-Art Review.

Authors:  Inderpaul Singh Sehgal; Nalini Gupta; Sahajal Dhooria; Ashutosh Nath Aggarwal; Karan Madan; Deepali Jain; Parikshaa Gupta; Neha Kawatra Madan; Arvind Rajwanshi; Ritesh Agarwal
Journal:  J Cytol       Date:  2020-04-02       Impact factor: 1.000

2.  Optimization of Sample Preparation Using Glass Slides for Spectral Pathology.

Authors:  Lewis M Dowling; Paul Roach; Abigail V Rutter; Ibraheem Yousef; Srinivas Pillai; Deborah Latham; Daniel G van Pittius; Josep Sulé-Suso
Journal:  Appl Spectrosc       Date:  2020-10-14       Impact factor: 2.388

3.  Tru-cut/core Biopsy versus FNAC: Pulmonary Tumors.

Authors:  Deepali Jain
Journal:  J Cytol       Date:  2018 Jul-Sep       Impact factor: 1.000

4.  Values of different specimen preparation methods for the diagnosis of lung cancer by endobronchial ultrasound guided transbronchial needle aspiration.

Authors:  Youzu Xu; Jian Lin; Meifang Chen; Haihong Zheng; Jiaxi Feng
Journal:  BMC Pulm Med       Date:  2020-05-15       Impact factor: 3.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.